ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.52
-1.13%
US Tech 100
20,263.20
-1.69%
S&P 500
5,827.04
-1.54%
US Dollar vs CAD
1.44391
0.16%
Bitcoin
94,156.47
-0.35%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Cellavision AB Foreign (PK) (CLVSF) Share Price

Cellavision AB Foreign (PK)

Cellavision AB Foreign (PK) (CLVSF)

USOTC
19.91
0.00
(0.00%)
Closed January 12 3:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
19.91
Bid
17.99
Ask
19.92
Volume
-
0.00 Day's Range 0.00
19.91 52 Week Range 25.905
Market Cap
474.884M
Previous Close
19.91
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
500
Shares Outstanding
23,851,547
Dividend Yield
-
PE Ratio
3.64
Earnings Per Share (EPS)
5.46
Revenue
677.29M
Net Profit
130.31M

About Cellavision AB Foreign (PK)

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.cellavision.com
Headquarters
Lund, Swe
Founded
-
Cellavision AB Foreign (PK) is listed in the Lab Analytical Instruments sector of the OTCMarkets with ticker CLVSF. The last closing price for Cellavision AB Foreign (PK) was US$19.91. Over the last year, Cellavision AB Foreign (PK) shares have traded in a share price range of US$ 19.91 to US$ 25.905.

Cellavision AB Foreign (PK) currently has 23,851,547 shares outstanding. The market capitalization of Cellavision AB Foreign (PK) is US$474.88 million. Cellavision AB Foreign (PK) has a price to earnings ratio (PE ratio) of 3.64.

Ask ADVFN Intelligence (AI)

CLVSF Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120019.9119.9119.9150019.91CS
26-4.3-17.761255679524.2125.90519.9120023.05125CS
52-3.84-16.168421052623.7525.90519.9122321.60293103CS
156-14.84-42.705035971234.7534.7516.7228925.38680388CS
260-9.54-32.393887945729.4535.287516.7233629.0587749CS

CLVSF - Frequently Asked Questions (FAQ)

What is the current Cellavision AB Foreign (PK) share price?
The current share price of Cellavision AB Foreign (PK) is US$ 19.91
How many Cellavision AB Foreign (PK) shares are in issue?
Cellavision AB Foreign (PK) has 23,851,547 shares in issue
What is the market cap of Cellavision AB Foreign (PK)?
The market capitalisation of Cellavision AB Foreign (PK) is USD 474.88M
What is the 1 year trading range for Cellavision AB Foreign (PK) share price?
Cellavision AB Foreign (PK) has traded in the range of US$ 19.91 to US$ 25.905 during the past year
What is the PE ratio of Cellavision AB Foreign (PK)?
The price to earnings ratio of Cellavision AB Foreign (PK) is 3.64
What is the cash to sales ratio of Cellavision AB Foreign (PK)?
The cash to sales ratio of Cellavision AB Foreign (PK) is 0.7
What is the reporting currency for Cellavision AB Foreign (PK)?
Cellavision AB Foreign (PK) reports financial results in SEK
What is the latest annual turnover for Cellavision AB Foreign (PK)?
The latest annual turnover of Cellavision AB Foreign (PK) is SEK 677.29M
What is the latest annual profit for Cellavision AB Foreign (PK)?
The latest annual profit of Cellavision AB Foreign (PK) is SEK 130.31M
What is the registered address of Cellavision AB Foreign (PK)?
The registered address for Cellavision AB Foreign (PK) is IDEON SCIENCE PARK, LUND, SE 223 70
What is the Cellavision AB Foreign (PK) website address?
The website address for Cellavision AB Foreign (PK) is www.cellavision.com
Which industry sector does Cellavision AB Foreign (PK) operate in?
Cellavision AB Foreign (PK) operates in the LAB ANALYTICAL INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
mining hound mining hound 4 minutes ago
Hi all, thanks for happy new year wishes and I wish the same for all here too!
HLLXF
gfp927z gfp927z 13 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 14 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 14 minutes ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 15 minutes ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 17 minutes ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 17 minutes ago
We will persevere!
AVXL
gfp927z gfp927z 18 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 18 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 18 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 21 minutes ago
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 22 minutes ago
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 22 minutes ago
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 23 minutes ago
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 26 minutes ago
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 28 minutes ago
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 29 minutes ago
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 29 minutes ago
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB
elks elks 30 minutes ago
Thanks.
RDAR
commdude commdude 30 minutes ago
I purchased some MJLink stocks a few years ago via their web portal. I assume they are pretty much worthless now, or????  

It wasn't a large investment, and just crossed my mind that I have them after revisiting this forum.
WDLF
TradingCharts TradingCharts 32 minutes ago
Page 2 Signed July 26, 2024

https://cases.stretto.com/public/X063/10210/PLEADINGS/1021007262480000000235.pdf
7. Stalking Horse. The Trustee has demonstrated a sound business justification for
the Court to approve (i) Meteor Energy, LLC or its designee as the Stalking
IBATF
Steady_T Steady_T 35 minutes ago
Good article with a positive slant. It did touch on the potential negatives to give some balance.

Hopefully that is enough depth to generate some interest in Anavex. He did make clear that the approval is likely to be late in the year.

At this point I see a lot of vola
AVXL
axelvento axelvento 36 minutes ago
Why Is There No Vaccine For Norovirus As It Spreads Across US? How Much Do You Need To Wait ?
Among the most promising is the vaccine candidate from Moderna—currently being tested in human participants, says Health.com

https://www.timesnownews.com/health/why-is-there-no-vaccine
MRNA
Oleblue Oleblue 36 minutes ago
D-Wave Announces 2024 Bookings and First On-Premise Advantage System Sale

Capital Markets, Quantum Computing Business

Cierra Choucair
January 10, 2025

D-Wave Quantum Inc. reported fiscal year 2024 bookings exceeding $23 million, a
QBTS

Your Recent History

USOTC
CLVSF
Cellavision AB Foreign (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads